Positive ID

Biological Detection and Diagnostics

PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats for homeland defense, as well as analyze biological samples at the point of care.

Click here to view our products

Recent News

February 26, 2014
PositiveID Corporation Provides 2013 Review and 2014 Outlook
more
February 13, 2014
PositiveID Corporation to Present at the National Investment Banking Association Conference on February 27-28, 2014
more
February 4, 2014
PositiveID Corporation Adds U.S. Homeland Security and Counter-Terrorism Expert Thomas DiNanno to Its Advisory Board
more
January 28, 2014
PositiveID Featured in Government Security News and Homeland Security Today
more
January 23, 2014
PositiveID Publishes Report on Its BioThreat Detection and Diagnostics Solutions
more
View Archives

PositiveID Corporation™ (OTCQB: PSID)

PositiveID Corporation™ is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.

M-BAND

PositiveID specializes in airborne pathogen detection, rapid clinical diagnostics and sample preparation applications. more

Company report

PositiveID and Secure Strategy Group have published a report on PositiveID. more

Firefly

PositiveID is developing a portable, handheld biological detection system. more

PositiveID™ Corporation, 2014 - All Rights Reserved